Remove Clinical Development Remove Drug Research Remove Small Molecule
article thumbnail

Bayer, Broad Institute Extend Cardiovascular Drug Research Pact

The Pharma Data

By leveraging large-scale genomic datasets and functional assays in human cardiomyocytes, researchers from Bayer and the Broad Institute are working to map the complex gene networks that drive disease progression in DCM and other cardiovascular disorders.

article thumbnail

Using clinical genomics and AI in drug development to elevate success

Drug Target Review

Addressing the long timelines and high costs of drug development is therefore critical for the advancement of medical innovation. Unfortunately, many drug candidates fail. Clinical development failure may be due to an inability to demonstrate efficacy or sufficient safety. Unfortunately, many drug candidates fail.